Dimensional Fund Advisors
CPRX

Dimensional Fund Advisors’s Catalyst Pharmaceutical CPRX Stock Holding History

Dimensional Fund Advisors’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$84.9M Buy
3,429,615
+433,318
+14% +$10.3M 0.02% 1171
2025
Q4 		$69.9M Buy
2,996,297
+538,128
+22% +$12M 0.01% 1318
2025
Q3 		$48.4M Buy
2,458,169
+550,648
+29% +$11.3M 0.01% 1537
2025
Q2 		$41.4M Sell
1,907,521
-279,901
-13% -$6.61M 0.01% 1606
2025
Q1 		$53M Sell
2,187,422
-825,610
-27% -$18.6M 0.01% 1437
2024
Q4 		$62.9M Sell
3,013,032
-5,757
-0.2% -$124K 0.02% 1374
2024
Q3 		$60M Buy
3,018,789
+18,033
+0.6% +$334K 0.01% 1401
2024
Q2 		$46.5M Buy
3,000,756
+263,099
+10% +$4.1M 0.01% 1511
2024
Q1 		$43.6M Buy
2,737,657
+135,860
+5% +$2.05M 0.01% 1555
2023
Q4 		$43.7M Buy
2,601,797
+41,923
+2% +$573K 0.01% 1539
2023
Q3 		$29.9M Buy
2,559,874
+87,464
+4% +$1.17M 0.01% 1689
2023
Q2 		$33.2M Buy
2,472,410
+97,902
+4% +$1.41M 0.01% 1644
2023
Q1 		$39.4M Buy
2,374,508
+65,803
+3% +$1.09M 0.01% 1506
2022
Q4 		$42.9K Buy
2,308,705
+165,138
+8% +$2.54M 0.01% 1419
2022
Q3 		$27.5M Sell
2,143,567
-99,081
-4% -$1.17M 0.01% 1640
2022
Q2 		$15.7M Buy
2,242,648
+97,394
+5% +$714K 0.01% 1993
2022
Q1 		$17.8M Buy
2,145,254
+241,686
+13% +$1.71M 0.01% 2026
2021
Q4 		$12.9M Buy
1,903,568
+149,594
+9% +$984K ﹤0.01% 2202
2021
Q3 		$9.29M Buy
1,753,974
+293,033
+20% +$1.6M ﹤0.01% 2361
2021
Q2 		$8.4M Buy
1,460,941
+274,474
+23% +$1.42M ﹤0.01% 2438
2021
Q1 		$5.46M Buy
1,186,467
+500,706
+73% +$1.99M ﹤0.01% 2549
2020
Q4 		$2.29M Sell
685,761
-1,473
-0.2% -$4.95K ﹤0.01% 2772
2020
Q3 		$2.04M Buy
687,234
+45,004
+7% +$176K ﹤0.01% 2736
2020
Q2 		$2.97M Buy
642,230
+95,868
+18% +$431K ﹤0.01% 2626
2020
Q1 		$2.1M Buy
546,362
+125,342
+30% +$514K ﹤0.01% 2695
2019
Q4 		$1.58M Buy
421,020
+16,990
+4% +$79.5K ﹤0.01% 2914
2019
Q3 		$2.15M Hold
404,030
– – ﹤0.01% 2845
2019
Q2 		$1.55M Sell
404,030
-3,200
-0.8% -$13.8K ﹤0.01% 2959
2019
Q1 		$2.08M Sell
407,230
-6,290
-2% -$18.5K ﹤0.01% 2887
2018
Q4 		$795K Buy
413,520
+151,738
+58% +$434K ﹤0.01% 3065
2018
Q3 		$990K Buy
+261,782
New +$820K ﹤0.01% 3068
2015
Q2 		– Sell
-46,438
Closed -$201K – 3366
2015
Q1 		$201K Hold
46,438
– – ﹤0.01% 3228
2014
Q4 		$138K Hold
46,438
– – ﹤0.01% 3281
2014
Q3 		$154K Hold
46,438
– – ﹤0.01% 3285
2014
Q2 		$117K Hold
46,438
– – ﹤0.01% 3360
2014
Q1 		$105K Hold
46,438
– – ﹤0.01% 3377
2013
Q4 		$91K Hold
46,438
– – ﹤0.01% 3360
2013
Q3 		$142K Hold
46,438
– – ﹤0.01% 3348
2013
Q2 		$41K Buy
+46,438
New +$37.2K ﹤0.01% 3455

Other funds holding CPRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors's CPRX Position: Q1 2026 in Review

Dimensional Fund Advisors increased its Catalyst Pharmaceutical (CPRX) stake by 14% in Q1 2026, buying an estimated $10.3M and bringing the position to 3,429,615 shares worth $84.9M. The position accounts for 0.02% of the portfolio, ranked #1171.

Dimensional Fund Advisors first reported a position in CPRX in Q2 2013 and has held it in 39 quarters since. 380 funds tracked by Wall St. Rank hold CPRX as of Q1 2026.

  • Dimensional Fund Advisors held 3,429,615 shares of Catalyst Pharmaceutical worth $84.9M as of Q1 2026.
  • Dimensional Fund Advisors bought 433,318 Catalyst Pharmaceutical shares in Q1 2026, an estimated $10.3M.
  • Catalyst Pharmaceutical made up 0.02% of Dimensional Fund Advisors's portfolio in Q1 2026, its #1171 holding.
  • Dimensional Fund Advisors first reported a position in Catalyst Pharmaceutical in Q2 2013 and has held it in 39 quarters since.
  • 380 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q1 2026.

Based on Dimensional Fund Advisors's 13F filing for Q1 2026, filed 7 May 2026.